Standard TDS Irritation Study: Trained Skin Grader vs. Digital Imaging

NCT02787356 · clinicaltrials.gov ↗

NA

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Project was not funded by FDA

Conditions

Skin Manifestations

Interventions

DRUG: TDS Lidocaine 5%; generic
DRUG: TDS Lidocaine 5%; RLD

Sponsor

SRI International

Collaborators

[object Object]